Antibiotics and Innovation

The history of antibiotics has repeated itself: drugs are discovered, but bacterial evolution can soon render them ineffective in treating infections. Resistance is fueled by injudicious use of existing drugs and compounded by a failure to develop novel new ones. Many major pharmaceutical companies have limited their investments in this antibiotic innovation, and only two new classes of these substances have reached the market in the past 30 years.

Pew’s work on antibiotics and innovation develops and supports policies that will spur innovation of new antibiotics to fight infections today and to ensure a healthy nation in the future.

Our Work

View All

Media Contact

Linda Paris

Officer, Communications